Continuous infusion of an agonist of the tumor necrosis factor receptor 2 in the spinal cord improves recovery after traumatic contusive injury-Reference-Cited by-同舟云学术

Continuous infusion of an agonist of the tumor necrosis factor receptor 2 in the spinal cord improves recovery after traumatic contusive injury

Published:2019-04-02 Issue: Volume: Page:
ISSN:1755-5930
Container-title:CNS Neuroscience & Therapeutics
language:en
Short-container-title:CNS Neurosci Ther

Author:

Gerald Marcus J.¹,Bracchi‐Ricard Valerie¹^ORCID,Ricard Jerome¹,Fischer Roman¹,Nandakumar Bharadwaj²³,Blumenthal Gary H.²³,Williams Raushaun¹,Kontermann Roland E.⁴⁵,Pfizenmaier Klaus⁴⁵,Moxon Karen A.²³,Bethea John R.¹

Affiliation:

1. Department of Biology Drexel University Philadelphia Pennsylvania

2. Department of Biomedical Engineering Drexel University Philadelphia Pennsylvania

3. Department of Biomedical Engineering University of California‐Davis Davis California

4. Institute of Cell Biology and Immunology University of Stuttgart Stuttgart Germany

5. Stuttgart Research Center Systems Biology University of Stuttgart Stuttgart Germany

Funder

Deutsche Forschungsgemeinschaft

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Pharmacology (medical),Physiology (medical),Psychiatry and Mental health,Pharmacology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cns.13125

Reference40 articles.

1. The cellular inflammatory response in human spinal cords after injury

2. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor

3. Involvement of the tumor necrosis factor receptor p75 in mediating cytotoxicity and gene regulating activities

4. Upregulation of NF-κB-Dependent Gene Expression Mediated by the p75 Tumor Necrosis Factor Receptor

5. TNF neutralization in MS: Results of a randomized, placebo-controlled multicenter study

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Systemic treatment with a selective TNFR2 agonist alters the central and peripheral immune responses and transiently improves functional outcome after experimental ischemic stroke;Journal of Neuroimmunology;2023-12

2. Therapeutic potential of TNFR2 agonists: a mechanistic perspective;Frontiers in Immunology;2023-08-17

3. TNF and TNF receptors as therapeutic targets for rheumatic diseases and beyond;Nature Reviews Rheumatology;2023-08-04

4. Selective Inhibition of Soluble Tumor Necrosis Factor Alters the Neuroinflammatory Response following Moderate Spinal Cord Injury in Mice;Biology;2023-06-12

5. Exercise therapy guides cortical reorganization after midthoracic spinal contusion to enhance control of lower thoracic muscles, supporting functional recovery;Experimental Neurology;2023-06